|
Infliximab Clinical Trials
5 actively recruiting trials across 4 locations
Also known as: Avakine, Remicade, Remsima, cA2
Pipeline
Phase 1: 1Phase 2: 1Phase 3: 1Phase 1/2: 1
Top Sponsors
- University of Nebraska1
- University of California, San Francisco1
- Swiss Dermatology Network for Targeted Therapies1
- Massachusetts General Hospital1
- M.D. Anderson Cancer Center1
Indications
- Cancer3
- Arthritis2
- Tumor Necrosis Factor-alpha1
- Vasculitis1
- Stage 0 Lung Cancer AJCC v81
Other1 trial
San Francisco, California1 trial
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
UCSF Medical Center
Phase 1/2
Boston, Massachusetts1 trial
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Massachusetts General Hospital
Phase 2
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
Houston, Texas1 trial
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M D Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.